首页|氢吗啡酮联合肋间神经阻滞在胸腔镜手术术后镇痛中的临床疗效

氢吗啡酮联合肋间神经阻滞在胸腔镜手术术后镇痛中的临床疗效

扫码查看
目的:探讨氢吗啡酮联合肋间神经阻滞在胸腔镜手术患者术后镇痛中的镇痛效果和安全性.方法:选取择期全身麻醉下行胸腔镜手术患者 120 例为研究对象,随机分为氢吗啡酮联合肋间神经阻滞组(H组)和舒芬太尼联合肋间神经阻滞组(S组)各 60 例.H组:术毕在超声引导下行肋间神经阻滞,手术结束前 0.5 h给予氢吗啡酮 2 mg,经静脉患者自控镇痛(PCIA,氢吗啡酮 0.2 mg/kg+昂丹司琼 16 mg+酮咯酸氨丁三醇注射液120 mg+生理盐水稀释至150 ml),PCIA泵入的负荷剂量为 2 ml,追加量为 2 ml,输注速度为 2 ml/h,锁定时间为 15 min.S组:术毕在超声引导下行肋间神经阻滞,手术结束前0.5 h给予舒芬太尼 10 μg,PCIA(2 μg/kg舒芬太尼+昂丹司琼 16 mg+酮咯酸氨丁三醇注射液 120 mg+生理盐水稀释至100 ml),PCIA泵入的负荷剂量为 2 ml,追加量为 0.5 ml,输注速度为 2 ml/h,锁定时间为 15 min.静脉滴注酮咯酸氨丁三醇注射液 30 mg进行补救镇痛,维持疼痛视觉模拟评分(VAS)3 分以下.比较两组VAS评分、Ramsay评分、躁动评分、静脉自控镇痛按压次数和酮咯酸氨丁三醇给药次数.观察两组患者手术后不良反应发生率,不良反应包括恶心、呕吐和头晕等症状,术后至出院期间肺部并发症.结果:与S组比较,H组术后 2 h、12 h、24 h、48 h的VAS评分均小于S组,差异有统计学意义(P<0.05);两组头晕发生率比较,差异有统计学意义(P<0.05);两组Ramsay评分、躁动评分、恶心呕吐、肺部并发症、镇痛泵按压次数、酮咯酸氨丁三醇给药次数比较差异无统计学意义(P>0.05).结论:氢吗啡酮联合肋间神经阻滞在胸腔镜手术患者中术后镇痛疗效确切.
Clinical efficacy of hydromorphone combined with intercostal nerve block in postoperative analgesia after thoracoscopic surgery
Objective To investigate the analgesic effect and safety of hydromorphone combined with intercostal nerve block in post-operative analgesia in patients undergoing thoracoscopic surgery.Method 120 patients underwent thoracoscopic surgery under elective general anesthesia were selected as research object.They were divided into hydromorphone combined with intercostal nerve block group(group H)and sufentanil combined with intercostal nerve block group(group S)with 60 cases in each group.Group H:After surger-y,the intercostoal nerve was blocked under ultrasound guidance.Half an hour before the surgery,2mg hydromorphone and PCIA(hydromorphone 0.2 mg/kg+ondansetron 16mg+ketorolac tropanol injection 120mg+normal saline diluted to 150 mL)were given.The loading dose of PCIA pump is 2ml,the supplementary dose is 2ml,the infusion speed is 2ml/h,and the locking time is 15min.Group S:After surgery,intercostal nerve block was administered under ultrasound guidance,and 10μg Sufentanil was given half an hour before the end of surgery,PCIA(2μg/kg sufentanil+ondansetron 16mg+ketorolac tropanol injection 120mg+normal saline dilu-ted to 100 mL).The loading dose of PCIA pump was 2ml,the supplementary dose was 0.5ml,the infusion speed was 2ml/h,and the locking time was 15min.Ketorolac ambutol injection 30mg was administered intravenously for remedial analgesia,and the VAS score was maintained below 3.The VAS score,Ramsay score,agitation score,the number of intravenous controlled analgesia compressions and the number of ketorolac troamine administration were compared between the two groups.The incidence of postoperative adverse re-actions,including nausea,vomiting and dizziness,and pulmonary complications from postoperative to discharge,were observed in the two groups.Results Compared with group S,the VAS scores of group H at 2h,12h,24h and 48h after operation were lower than those of group S,with statistical significance(P<0.05).There was statistical significance in the incidence of dizziness between the two groups(P<0.05).There was no significant difference in Ramsay score,agitation score,nausea and vomiting,pulmonary complica-tions,analgesic pump compression times,and ketorolac tropanol administration times between group H and group S(P>0.05).Con-clusion Hydromorphone combined with intercostal nerve block is effective in postoperative analgesia in patients undergoing thoraco-scopic surgery and is worthy of clinical application.

HydromorphoneIntercostal nerve blockThoracoscopic surgery

田艳艳、崔常雷、张维政、管向臣

展开 >

临沂市平邑县人民医院麻醉科,山东 临沂 273300

吉林大学第一医院麻醉科

临沂市平邑县人民医院胸心外科

氢吗啡酮 肋间神经阻滞 胸腔镜手术

山东省医学会镇痛镇静-麻醉优化专项课题

YXH2022ZX05261

2024

吉林医学
吉林省人民医院

吉林医学

影响因子:0.926
ISSN:1004-0412
年,卷(期):2024.45(8)
  • 8